Praxis Precision Medicines, Inc. PRAX Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Praxis Precision Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.
The official record: Praxis Precision Medicines, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Praxis Precision Medicines, Inc.'s short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Praxis Precision Medicines, Inc.'s short-term investments?
- Praxis Precision Medicines, Inc. (PRAX) reported short-term investments of $250.53M in Q1 2026.
- How has Praxis Precision Medicines, Inc.'s short-term investments changed year-over-year?
- Praxis Precision Medicines, Inc.'s short-term investments increased by 54.2% year-over-year, from $162.42M to $250.53M.
- What is the long-term trend for Praxis Precision Medicines, Inc.'s short-term investments?
- Over 4 years (2021 to 2025), Praxis Precision Medicines, Inc.'s short-term investments has grown at a 23.0% compound annual growth rate (CAGR), from $105.68M to $242M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.